×

UPSC Courses

DNA banner

DAILY NEWS ANALYSIS

  • 16 March, 2021

  • 5 Min Read

AstraZeneca- Reports of blood clots

AstraZeneca- Reports of blood clots

Data of global Covid-19 vaccination

  • A little over 392 million doses of vaccine have been administered globally, according to the Bloomberg Vaccine Tracker, with India accounting for around 9% of them.

Reports of blood clot

  • In the last week, there have been a flurry of reports from Europe, of blood clots developing in a very small fraction of those vaccinated and leading to a cascade of European countries announcing a temporary halt to their vaccination programmes involving the AstraZeneca (AZ) vaccine.
  • WHO and the European Medicines Agency have underlined that there is no causal link between vaccines and the occurrence of such clots.
  • In fact, there are less than 40 such occurrences reported so far, and that is much below the background of about 1,000 to 2,000 blood clots every single day in the general population, say studies based on the U.S. population.

Note:

  • By far the largest user of the AstraZeneca vaccine is India. India is using two vaccines -- the AstraZeneca (a.k.a COVISHIELD)shot made by Serum Institute of India, and another one by Indian vaccine maker Bharat Biotech (COVAXIN/PFIZER) -- to immunize its vast population

  • These organisations advocate that the ongoing vaccination drives continue, even accelerate, as the rate of vaccination is not keeping pace with what is required to control the pandemic.

Issues with the approved Covid vaccines

  • The AZ, Pfizer and Moderna vaccines have been released under emergency use authorisations, meaning that the entire profile of risks associated with them have not been thoroughly studied.
  • History is replete with instances of vaccines that have been taken off even years after approval after a slight increase in untoward complications.
  • As of now, the risk of dying from serious COVID-19 far outweighs that from vaccine reactions and it is such a calculation that weighs on the minds of regulators before approving vaccines.
  • Unlike drugs administered to the sick, vaccines have a higher bar of proving themselves safe as they are given to the healthy.
  • Regulators of all countries rely on the experiences of others, as exemplified in India alone where it was AZ trials in the United Kingdom that paved the way for approval in India.
  • Therefore, a warning in one country must immediately activate the sensors in another.
  • India has a long experience with vaccinations as well as expertise in evaluating risk; however, transparency and prompt data sharing, thereby building public trust, is not one of its strong suits.
  • This was evidenced by the approval of vaccines in spite of scant efficacy data.
  • There is almost no information by the National Committee on Adverse Events Following Immunisation on the nature of serious adverse events following immunisation.
    • This is in contrast to the frequent analyses shared by organisations such as the U.S. Centre for Disease Control and Prevention on adverse events.

Way ahead

  • Public trust is a key ingredient to successful vaccination programmes and this can be only earned by the government’s zealous attention to allaying concerns.

What is Vaccination hesitancy ?

  • Refers to delay in acceptance or refusal of vaccines despite

availability of vaccine services.

  • Is complex and context specific varying across time, place and vaccines.
  • Is influenced by factors such as complacency, convenience and confidence.

Source: TH


Rajasthan First State to Implement Biofuel Policy

  Rajasthan First State to Implement Biofuel Policy: (GS-II(Policies) & GS-III(Environment)) Theme: Biofuel Policy Rajasthan has become the first State in the country to implement the national policy on biofuels unveiled by the Centre in May 2018.   The desert State will lay emphasis on increasing production of oils

SEHAT Scheme for Teleconsultation

Services e-Health Assistance and Teleconsultation (SeHAT) is the tri-services teleconsultation service of the Ministry of Defense designed for all entitled personnel and their families. As part of the Government’s commitment to Digital India and e-Governance, Minister of Defense launched SeHAT on 27 May 2021. It has been a great exam

PM Poshan Scheme to replace Mid Day Meal Scheme

PM Poshan (Erstwhile Mid Day Meal) Scheme Cabinet has approved the Prime Minister POSHAN scheme or PM-POSHAN for providing one hot cooked meal in Government and Government-aided schools. The scheme will replace the existing national programme for mid-day meal in schools or Mid-day Meal Scheme (launched in 1995). It has been launched for a

National Initiative for Design Innovation (NIDI)

National Initiative for Design Innovation (NIDI) Government launched the scheme of “National Initiative for Design Innovation (NIDI)” in March, 2014. Scheme envisaged establishment of 20 Design Innovation Centres (DIC), One Open Design School (ODS) and One National Design Innovation Network (NDIN) across the country for promoti

Saffron cultivation in India

Saffron is a plant whose dried stigmas (thread-like parts of the flower) are used to make saffron spice. Saffron cultivation is believed to have been introduced in Kashmir by Central Asian immigrants around the 1st Century BCE. Pampore region, in India, commonly known as Saffron bowl of Kashmir, is the main contributor to saffron p

Students Achievement

Search By Date

Newsletter Subscription
SMS Alerts